Your search results

Athena has developed fixed-dose combination (FDC) formulations for multiple active ingredients combined in a single dosage. Further, Athena has added value to the FDC by using the relevant technology platform to make it the more patient complaint. FDC drug products are known to improve medication compliance of Patients by reducing the pill burden of patients, as well as giving the inherent advantages of combination therapy.

Advantages with FDCs

Simpler dosage schedule giving excellent patient compliance and therefore improves treatment outcomes
Reduces inadvertent medication errors
Synergistic effects on the dosage regimen
Side effects are reduced by using one drug of the combination for this purpose

FDC’s from Athena

Paracetamol 325mg + Tramadol 37.5mg Plain Tablet and ODT – ODT marketed by Novartis under Palitex® Brand in India
Voglibose 0.2/0.3mg + Metformin 500mg Tablet – Marketed by AstraZeneca Vigocil M® and Novartis Vingose Met® in India

Compare Listings